Showing 931-940 of 3315 results for "".
Gut Health Linked with Dry Eye Disease
https://modernod.com/videos/eye-care-insiders/gut-health-linked-with-dry-eye-disease/39854/The gut microbiome plays a key role in systemic health, and dysregulation of the gut microbiota can lead to any number of complications, including dry eye. In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, discusses the current literature linking dry eye with gut dysbiosis and what ODs can do toAlcon Acquires Staar for $1.5 Billion
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-staar-for-15-billion/37096/Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week. Learn more about your ad choices.Alcon Acquires LumiThera
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-lumithera/37092/Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: Update on Holland Foundation
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-update-on-holland-foundation/37090/The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease. Learn more about your ad choices. Visit megaphone.fm/adchoicesFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Issues CRL to Regeneron for Eylea HD Extended Dosing
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-issues-crl-to-regeneron-for-eylea-hd-extended-dosing/37081/The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoicesOrasis Launches Presbyopia Eye Drop Qlosi
https://modernod.com/podcasts/eyewire-news-the-podcast/orasis-launches-presbyopia-eye-drop-qlosi/37080/A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a presbyopia eye drop candidate. Learn more about your ad choices. Visit megaphone.fm/adchoicesSleep + DED • Motivating Staff
https://modernod.com/podcasts/the-mod-pod/sleep-ded-motivating-staff/36878/This month on The MOD Pod, host Cecelia Koetting, OD, FAAO, Dipl ABO, welcomes guests Josh Davidson, OD, FAAO, FSLS, and Marlon Monelyon-Demeritt, OD, MBA, FAAO. Dr. Koetting and Dr. Davidson discuss the relationship between sleep and risk level of dry eye disease, with Dr. Davidson citing studies tFDA Expands Product Label for Iluvien
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-expands-product-label-for-iluvien/37076/Iluvien receives a major label expansion; Bausch and Lomb launches a new orthokeratology lens fitting system; and several updates are announced in development wet AMD candidates. Learn more about your ad choices. Visit megaphone.fm/adchoicesKeratoconus Essentials: Genetic Screening, Early Detection, and Treatment Options
https://modernod.com/podcasts/the-mod-pod/keratoconus-essentials-genetic-screening-early-detection-and-treatment-options/36875/This month on The MOD Pod, Cecelia Koetting, OD, FAAO, invites Kriti Bhagat, OD, FAAO, to talk about key signs of keratoconus and the importance of screening family members. Dr. Bhagat also explains her strategy for encouraging patients to try specialty contact lenses. Continuing the keratoconus con